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We previously developed a highly speciﬁc method for detecting SNPs with a microarray-based system using stem-loop probes. In
this paper we demonstrate that coupling a multiplexing procedure with our microarray method is possible for the simultaneous
detection and genotyping of four point mutations, in three diﬀerent genes, involved in Charcot-Marie-Tooth disease. DNA
from healthy individuals and patients was ampliﬁed, labeled with Cy3 by multiplex PCR; and hybridized to microarrays. Spot
signal intensities were 18 to 74 times greater for perfect matches than for mismatched target sequences diﬀering by a single
nucleotide (discrimination ratio) for “homozygous” DNA from healthy individuals. “Heterozygous” mutant DNA samples gave
signal intensity ratios close to 1 at the positions of the mutations as expected. Genotyping by this method was therefore reliable.
This system now combines the principle of highly speciﬁc genotyping based on stem-loop structure probes with the advantages of
multiplex analysis.
Copyright © 2009 Yasser Baaj et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Introduction
The need for eﬃcient large-scale genotyping methods has
rapidly increased over the last ten years. Microarray-based
methods oﬀer a convenient solution to this need, but mul-
tiplexing is essential to increase the power of this approach
for detection and discrimination. This multiplexing can be
achieved in several ways, including reducing the complexity
of the genome before genotyping. This is achieved by
cleaving genomic DNA into fragments with a restriction
enzyme and then introducing common adaptor sequences
into the restriction products by ligation. These common
sequences are then used as binding sites for common
PCR primers [1, 2]. This approach is used in high-density
microarrays based on the Aﬀymetrix resequencing system
(Aﬀy m e t r i x ,S a n t aC l a r a ,C a l i f ,U S A )[ 2, 3]. Long-range
PCR for amplifying long PCR fragments, up to 10kb in
length, in each individual PCR has also been described [4, 5].
The Molecular Inversion Probe assay (Parallele Biosciences,
South San Francisco, Calif, USA) [6] uses probes that can
becircularizedandcontaintwosequencescomplementaryto
regions adjacent to SNPsin the DNA target in the ﬁrst step of
the genotyping reaction. These reactions produce templates
that can be ampliﬁed by PCR, using universal primer
sequences.Thebindingsitesfortheseprimersareintroduced
via the “circularizable” detector probes. The GoldenGate
assay (Illumina, San Diego, Calif, USA) [7, 8]i sb a s e d
on a similar principle but includes two oligonucleotides
ﬂanking the SNPs for the genotyping reactions. Finally, the
poolingofDNAsamplesormultiplexPCRstrategiesforSNP
genotyping have also been described in several microarray
methods, such as the original arrayed primer extension
(APEX) [9–12] or single base extension (SBE-tags) [13, 14]
assays.
We previously developed a highly speciﬁc genotyping
method based on hairpin probes. Our probes, also called2 Research Letters in Biochemistry
hairloops, consist of a GC-rich stem and a target-speciﬁc
loop [15]. After hybridization with perfectly complementary
labeled targets, the stems of probes are opened for the
subsequent detection of these targets. One of the major
limitations of our original method was the use of individual
PCR products, ampliﬁed separately, for the hybridization
and genotyping reaction. We show here that the multiplex
genotyping of multiple mutation sites is possible, based on
multiplex PCR DNA ampliﬁcation and a stem-loop probe
method.
2.MaterialsandMethods
2.1. DNA Extraction and Gene Mutations. DNA was
extracted from blood samples with the Nucleon extraction
and puriﬁcation kit (RPN8512, Amersham Biosciences, GE
Healthcare AB, Uppsala, Sweden), used according to the
manufacturer’s instructions. DNA concentration and purity
were determined by spectrophotometry (Shimadzu, UV-
160A). All DNA sequences for the three genes known to
be involved in CMT disease, for healthy individuals and
patients, were conﬁrmed by direct sequencing. The DNA of
eachpatientboresoneheterozygousmutationinoneofthese
genes. Four heterozygous point mutations were typed in the
three genes implicated in CMT disease. These mutations
were the V95M mutation in exon 2 of the GJB1 (Cx32) gene
(GenBank accession number XM 047682), the V113F and
T124M mutations in exon 3 of the MPZ (P0) gene (GenBank
accession number D10537), and the C42R mutation in
exon 3 of the PMP22 gene (GenBank accession number
L03203). Gene sequences were obtained from GenBank
(http://www.ncbi.nlm.nih.gov/).
2.2. Primers and Multiplex PCR Ampliﬁcation. Three
primer pairs were designed for the multiplex assay,
generating three amplicons of diﬀerent sizes. These
primer pairs were designed with primer3 software
(http://primer3.sourceforge.net/). The sequences of all
forward and reverse primers, their selected targets, and the
predicted sizes of the PCR products are shown in Table 1.
For each pair, the downstream primer corresponded to
the 5
  end labeled with Cy3. Primers were purchased from
Sigma-Proligo (St Louis, Mo, USA) and were 23 to 25 bases
long. The primers were designed to amplify the genomic
region surrounding the point mutations studied. Part of the
long exon 2 of the GJP1 gene, exon 3 of the MPZ (P0) gene,
and exon 3 of the PMP22 gene was ampliﬁed simultaneously
in the multiplex reaction. For PCR, we used the QIAGEN
multiplex PCR kit (Qiagen, Hilden, Germany) with 2x
QIAGEN multiplex PCR master mix. In a total volume of
50µL(ﬁnalconcentration,1xmastermix),theconcentration
of each primer was 0.2µMa n dt h a to fM g C l 2 was 3mM. We
used 100ng of DNA for each reaction. Ampliﬁcations were
carried out in a GeneAmp-PCR System 9700 thermal cycler
(Applied Biosystems, Foster City, Calif, USA), according to
the following protocol: 15 minutes at 95
◦C (initial activation
step), followed by 35 cycles of 94
◦C for 30 seconds, 68
◦C
for 90seconds, and 72
◦C for 90 seconds. The ﬁnal extension
step at 72
◦Cl a s t e d1 0m i n u t e s .A m p l i ﬁ c a t i o np r o d u c t sw e r e
concentrated and puriﬁed with a QIAquick Gel Extraction
Kit (Qiagen, Hilden, Germany), and their concentrations
were then determined by spectrophotometry (Shimadzu,
UV-160A). Finally, 6µg of each multiplex ampliﬁcation
mixture was hybridized separately to a microarray.
2.3. Microarray, Probes and Hybridization. Microarrays
were purchased from Serial Genetics (Evry, France)
(http://www.serialgenetics.com/) .T h ep r o b e sw e r ed e s i g n e d
such that their loops were complementary to the related
downstream labeled ampliﬁed PCR products. The sequences
of wild-type and mutant probes (4 of each) are given
in Table 2. Two hairloop probes were designed for each
mutation—one for the normal allele and one for the
mutant allele—giving a total of eight speciﬁc probes. The
hybridization mixture consisted of a total volume of 15µL
containing 6µg labeled multiplex PCR products in 50%
formamide, 0.09M sodium citrate, 0.9M NaCl, pH 7.1.
Before hybridization, this mixture was denatured by heating
at 98
◦C for 3 minutes. Each array was hybridized under a
22 × 22mm coverslip (Sigma-Aldrich, The Woodlands,
Tex, USA) for two hours at room temperature. After
hybridization, slides were washed at room temperature for 4
minutes in 0.015M sodium citrate, 0.15M NaCl, pH 7.1 (1
× SSC) supplemented with 0.2% SDS, for 3 minutes in 1 ×
SSC with gentle shaking and then for 3 minutes in 0.1 × SSC
with gentle shaking. The slides were dried by centrifugation
for 4 minutes at 800rpm (Jouan CR312, Saint-Herblain,
France).
2.4. Scanning and Signal Analysis. The mean Signal-
Background (S-B) intensity for each spot was calculated
for the ﬁve replicates of each spot, using an IMSTAR OSA
(Optical Scan Array) Reader. S-B intensities were then used
for the calculation of discrimination ratios. The DR for each
probe was deﬁned as the ratio between the signal obtained
on hybridization with the perfect complementary target (i.e.,
WTtargetwithWTprobe,orMTtargetwithMTprobe)and
the signal obtained on hybridization with the mismatched
target (i.e., MT target with WT probe, or WT target with MT
probe). The discrimination ratio for the WT target was thus
S-B spot WT/S-B spot MT; whereas the discrimination ratio
for the MT target was S-B spot MT/S-B spot WT.
3. Results
Genomic DNA from healthy individuals and patients with
CMT was separately subjected to multiplex PCR ampliﬁ-
cation. Cy3-labeled multiplex PCR products derived from
eachampliﬁcationreactionwashybridizedandanalyzedona
single microarray. After scanning, each sample was tested for
the presence or absence of the mutant allele. Discrimination
ratios were then calculated to assess the speciﬁcity of the
method. For a given multiplex reaction hybridization, each
experiment performed gave four diﬀerent DRs: one for each
of the mutation positions studied. Each DR indicated the
presence of one of two possible genotypes: homozygousResearch Letters in Biochemistry 3
Table 1: Genes, detected mutations and primers used for multiplex PCR and ampliﬁed fragment lengths.
Primers Mutation Gene Exon ampliﬁed Tm GC% Fragment length (bp) Primer sequence
Multi 1 (F) V95M Cx32 Exon 2 67.20 45.83 574 bp AGCTTGCTTCATGGCTGGTGTTTT
Multi 1 (R) 67.15 59.09 ACTGTGTTGGGGCAGGGGTAGA
Multi 2 (F) V113F P0 Exon 3 67.86 52.00 285 bp CTCTCACATGCTTCCCCTCATTCCT
Multi 2 (R) T124M 67.70 52.00 CAAACTGCTTCCCATACCCTTGTCC
Multi 3 (F) C42R PMP22 Exon 3 67.78 52.00 197 bp TCCTTCCCCTTTTCCTTCACTCCTC
Multi 3 (R) 67.66 48.00 ACAAGCTCATGGAGCACAAAACCAG
Table 2: Probe sequences.
Gene mutation WT spotted probe sequence MT spotted probe sequence
V95M GCGCCGATGCACGTGGCTCACGGCGC GCGCCGATGCACATGGCTCACGGCGC
V113F GCGAGCGCTCCATTGTCATACACAAGCTCGC GCGAGCGCTCCATTTTCATACACAAGCTCGC
T124M GCGAGCCAATGGCACGTTCACTTGCTCGC GCGAGCCAATGGCATGTTCACTTGCTCGC
C42R GCGAGCCAGAACTGTAGCACCGCTCGC GCGAGCCAGAACCGTAGCACCGCTCGC
WT, resulting from the hybridization of WT targets with
WT probes or heterozygous MT, due to the hybridization
of MT and WT targets together, each with its perfect
complementary probe (i.e., WT target with WT probe, or
MT target with MT probe). In our study, each DNA sample
with mutated sequences contained only one heterozygous
mutation.
Hybridization of the ampliﬁed wild-type sequence DNA
showed a clear wild-type homozygous genotype, with spe-
ciﬁc hybridization to WT probes for the four mutation
positions, giving strong positive signals. The four calculated
DRs for these probes were high and ranged from 17.58
to 73.7. The hybridization of ampliﬁed mutant sequence
DNA (heterozygous) was also highly speciﬁc and gave strong
positivesignals.Thesesampleswerealsogenotypedcorrectly.
Four DRs were obtained: one corresponding to the existing
mutation position and three corresponding to the normal
sequence for the other three mutation positions studied. The
calculated DRs of these hybridizations at the existing muta-
tion position ranged from 0.24 to 3.2 and were systematically
below the value of ﬁve arbitrarily deﬁned as the threshold for
the genotyping of heterozygous sequences. These DRs gave
heterozygous MT genotypes. The DRs obtained for the other
three positions (each WT) in this hybridization indicated
homozygous WT genotypes and were above 14 (data not
shown). Only DRs at the positions of the mutations after
the hybridization of DNA from patients were considered
from the four DRs obtained for calculation of the power of
discrimination between genotypes.
Power of discrimination between genotypes was also
calculated by dividing the ratio of signals from normal and
mutant alleles at a homozygous position (DR, homozy-
gous) after WT sequence hybridization with the ratio of
signals at a heterozygous position (DR, heterozygous) after
heterozygous MT sequence hybridization. This discrimina-
tion power was high, ranging from 19 to 211 for each
mutation position. Table 3 provides a summary of the
discrimination ratios and discrimination powers obtained
in this study, and Figure 1 provides an example of the
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Figure 1: Hybridization speciﬁcity. Each spot type on the
microarray was presented in ﬁve vertical replicates. (a) Hybridiza-
tion of ampliﬁed DNA from healthy individuals (WT). All WT
probe types corresponding to hybridized targets were detected.
(b) Hybridization of mutant sequence DNA (C42R). WT and MT
probes for the heterozygous C42R mutation were clearly detected
withadiscriminationratioof2.2.AllotherWTspotscorresponding
to hybridized targets were also detected.
typical results obtained following multiplex ampliﬁed DNA
hybridization for a healthy individual or a patient (C42R
MT).
4. Discussion
Microarray approaches linked to nucleic acid analysis are
emerging as powerful tools for the multiplex genotyping
of SNPs and large-scale mutation screening. In this study,
we established proof-of-principle for the use of hairpin-
shaped probe microarrays for genotyping multiple muta-
tion positions and rapidly analyzing DNA sequences by4 Research Letters in Biochemistry
Table 3: Genotyping, discrimination ratios, and discrimination powers for healthy individuals and patients with CMT.
Mutation Sample genotype
(S-B) of
wild-type
allele probe
(SB) of mutant
allele probe
Discrimination ratio DNA type
Power of
discrimination
between genotypes
V95M Homozygous Wild-type 33.4 1.9 WT Probe: 17.58 Normal control
19
Heterozygous 8.6 8 MT Probe: 0.93 Patient
V113F Homozygous Wild-type 233.65 3.17 WT Probe: 73.7 Normal control
23
Heterozygous 111.8 362.7 MT Probe: 3.2 Patient
T124M Homozygous Wild-type 181.09 3.58 WT Probe: 50,58 Normal control
211
Heterozygous 138.3 33.9 MT Probe: 0.24 Patient
C42R Homozygous Wild-type 141.18 2.15 WT Probe: 65.66 Normal control
30
Heterozygous 55.6 126 MT Probe: 2.2 Patient
Signal-Background (S-B) calculations for each spot bearing the wild-type or mutant allele were obtained after the hybridization of PCR products from
heterozygous patients and unaﬀected individuals. The discrimination ratio between mutant and normal allele probes should be as high as possible for healthy
individuals (homozygous wild-type genotypes) and as close as possible to 1 for heterozygous aﬀected patients. The discrimination power should be as high as
possible.
hybridization. Each pair of probes (WT and MT) was
previously tested in individual PCRs and was demonstrated
to ﬁve correct genotypes [15]. In this study, we set up a
ﬂuorescent multiplex polymerase chain reaction (PCR) for
amplifying four loci located in three diﬀerent genes in the
same reaction. DNA from healthy individuals and from
patients with CMT disease was analyzed on hairloop arrays
designed to detect the presence or absence of heterozygous
mutations. The four loci in the multiplex system provide
useful information about polymorphism for mutation geno-
typing. The multiplexing procedure used did not aﬀect
speciﬁcity but did increase eﬃciency. The signal intensities
of wild-type probes were 18 to 74 times higher than those of
thehomologousmutantsequenceprobesdiﬀeringbyasingle
nucleotide (DR) from healthy individual “homozygous”
DNA. “Heterozygous” mutant DNA samples gave signal
intensity ratios close to 1 at mutation positions, as expected
for wild-type and mutant sequence signals of approximately
equivalent intensity.
The reported values for (S-B) of wild-type allele probe
(S-B) of mutant allele probe, and consequently discrimi-
nation ratios were diﬀerent between our herein study and
our previous publication [15]. This diﬀerence is mainly of
technical nature and is due to the fact that the hybridization
signals and ratio values strongly depend on the speciﬁc and
proper background value of each array. This background
value is somehow correlated to the quantity of hybridized
DNA and ﬂuctuates between arrays even when using the
same washing conditions. For these reasons, ratios of (S-B)
valuescorrespondingtowildtypeormutantalleleswereused
for calculating discrimination ratios.
After multiplex PCR product hybridization, the discrim-
ination ratio for a given mutation concerning wild type
“homozygous” DNA samples was lower than that obtained
with individually ampliﬁed samples [15]. This diﬀerence
may be due to the reduced availability of hairpin probes for
hybridization due to the high quantity (6µg) of multiplex
PCR products used here. Moreover, the noncomplementary
PCR products to a given probe could, by their quantity,
prevent hybridization of other PCR products with their
corresponding complementary probes. The raised back-
ground value, which generates a decrease in S-B values
after hybridization of 6µg multiplex PCR products, is an
additional cause for this diﬀerence of DRs. What is very
important to note though, is that S-B valuesof thetwo alleles
for “heterozygous” mutant DNA samples were always almost
equal and conserved a DR close to 1.
The high quantity of hybridized DNA should be then
reconsidered in the future. The amount of multiplex PCR
product used for hybridization could be decreased by
increasing labeling eﬃciency. This could be achieved by
incorporating several labeled nucleotides during ampliﬁca-
tion or by labeling the DNA after PCR ampliﬁcation, using
commercialkitsspeciallydesigned forthispurpose. Methods
used for the ampliﬁcation of single stranded PCR products
or for breaking the target into smaller fragments would also
be required in this approach. Our intention here was to
demonstrate that it is feasible to multiplex hairloop-based
microarrays. We think that the ability to genotype SNPs
with multiplex PCR reactions and easily generated speciﬁc
microarrays would make this approach eﬀective, rapid, and
inexpensive.
Finally, we compared our system with other known
microarray-based genotyping systems for multiplex SNP
detection. Some of these methods, such as SBE-tags [13]
and APEX [11, 16, 17] methods, have levels of multiplexing
and genome complexity reduction similar to those of our
method. However, the use of diﬀerent labeled dideoxynu-
cleotides by these methods increases the cost. Moreover,
these methods require the inclusion of an extension step,
in addition to clean-up and heat inactivation steps, none
of which are necessary in our method, which is therefore
simpler and faster.
Other multiplexing methods such as long-range PCR
[4, 5] or the use of universal primers [1, 2], based on
the use of allele-speciﬁc hybridization on high-density
microarrays (e.g., Aﬀymetrix “GeneChip” arrays); have also
been described. These assays use large numbers of probes (10Research Letters in Biochemistry 5
to 14) per SNP variant and require very large microarrays
[18], whereas our method is based on the use of a single
probe for each variable nucleotide. These microarrays must
be also produced by specialized industrial companies. The
signals obtained with these arrays are generally acquired
and analyzed with special scanners and software obtained
from the manufacturer and developed especially for these
purposes. This greatly increases the cost of these systems,
which are not cost-eﬀective for genotyping intermediate
numbers of SNPs, as in our system.
The Molecular Inversion Probe (Parallele Biosciences)
[6] and GoldenGate (Illumina) [7, 8] assays are also subject
to this problem. Both require several long specialized
multiplexing procedures. Speciﬁc sets of probes or oligonu-
cleotides bearing particular tag sequences must be designed
for each SNP site. This increases the complexity of this assay,
resulting in larger setup costs.
Our method is clearly simpler and faster than most of
these tests and could be presented as a more cost-eﬀective
and time-saving alternative particularly for intermediate
(tens to hundreds of sites) numbers of SNPs ($50/sample). It
would be straightforward to adapt this method to individual
academic research laboratories with classical scanners and
array equipment. The short hybridization step (2hours)
at room temperature is also an important feature of our
method, in addition to the low costs of primer synthesis,
due to a single 5
  amino linker modiﬁcation. The hairloop
method, with its corresponding multiplexing power, may be
modiﬁed for various applications and may hold considerable
promise, not only for the multiplex detection of SNPs, but
also for gene proﬁling and expression studies.
Abbreviations
CMT: Charcot-Marie-Tooth disease
CHR: Cross-hybridization rate
DR: Discrimination ratio
WT: Wild-type sequence of probe or target
MT: Mutant type sequence of probe or target, for
example,
V95M WT: Probe or target bearing the wild-type allele
of the V95M mutation;
V95M MT: Probe or target bearing the mutant allele of
the V95M mutation.
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